The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for ...
Intra-articular corticosteroid injection is associated with a reduced use of pain medications, including opioid combinations, ...
Latigo Biotherapeutics raises $150M Series B to advance Nav1.8 inhibitors for pain, competing with Vertex's Journavx.
Proceeds from today’s financing, when added to existing cash, fund operations through Q1 2026The Company is planning to announce interim data ...
In a new study published in the journal GeroScience, VAS101 (Vasceptor®), a novel curcumin transdermal formulation developed ...
Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...
A multidisciplinary team of University of Cincinnati Cancer Center researchers is leading a new clinical trial aimed to ...
Tonix stock, on last look, is up 24.4% to $13.57 as of 12:58 p.m. GMT-5 on Thursday. Two double-blind, placebo-controlled ...
The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
News-Medical.Net on MSN10d
New clinical trial aims to optimize pain management and reduce opioid use after mastectomyA multidisciplinary team of University of Cincinnati Cancer Center researchers is leading a new clinical trial aimed to optimize pain management and reduce the need for opioids after mastectomy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results